Sartorius Stedim Biotech S.A.
SRTOY · OTC
Market closed$21.24$0.045000 (+0.21%)After hours $21.24 · 0.00%
Key statistics
Previous close$21.19
Open$21.11
Day high$21.60
Day low$20.69
52-week high$26.54
52-week low$17.25
Market cap206.60B
Volume100.00
Average volume32.15K
P/E ratio110.37
Forward P/E—
EPS0.19
Dividend yield+0.37%
Market context
Why it moved
SRTOY edged modestly higher despite a broader risk-off environment on Wall Street, as a chip-led selloff and AI spending concerns weighed on major indices, suggesting the stock showed resilience amid the wider market turbulence.
What is happening
Recent company-specific developments and publisher coverage.
ad-hoc-news.de · July 18, 2026Sartorius Stedim stock stabilizes as bioprocess demand supports revenue growthAd Hoc News · July 17, 2026Sartorius Stedim stock trades steady as bioprocess margins draw attentionwww.marketscreener.com · July 3, 2026Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim BiotechSimply Wall Street · April 26, 2026Earnings Miss: Sartorius Stedim Biotech S.A. Missed EPS By 7.2% And Analysts Are Revising Their ForecastsSeeking Alpha · April 23, 2026Sartorius Stedim Biotech S.A. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:SRTOY) 2026-04-23Investing.com · March 30, 2026Goldman Sachs upgrades Sartorius Stedim to “buy,” sees 28% upsideIdéal Investisseur · February 6, 2026Sartorius Stedim Biotech: Proposed Dividend of €0.69White & Case LLP · February 8, 2024White & Case advises on €1.4 billion capital raise by Sartorius Group